Reports for MINT PHARMACEUTICALS INC
Company Name
MINT PHARMACEUTICALS INC
Shortage reports
Actual shortage:
18 (13%)
Anticipated shortage:
0 (0%)
Avoided shortage:
1 (1%)
Resolved:
121 (86%)
140
Discontinuation Reports
To be discontinued:
0 (0%)
Discontinued:
29 (100%)
Reversed:
0 (0%)
29
34 (20%)
16 (89%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-ALENDRONATE | 70.0MG | TABLET | Actual shortage | 2024-01-26 | 2025-04-11 | 217366 |
| MINT-AMLODIPINE | 10MG | TABLET | Resolved | 2018-04-12 | 2018-05-29 | 45528 |
| MINT-AMLODIPINE | 5MG | TABLET | Resolved | 2017-11-21 | 2018-01-11 | 30002 |
| MINT-ANASTROZOLE | 1MG | TABLET | Resolved | 2024-01-26 | 2024-03-26 | 217369 |
| MINT-ANASTROZOLE | 1MG | TABLET | Actual shortage | 2025-01-27 | 2025-01-28 | 248689 |
| MINT-ATORVASTATIN | 40MG | TABLET | Resolved | 2024-01-29 | 2024-01-30 | 217696 |
| MINT-ATORVASTATIN | 20MG | TABLET | Resolved | 2024-01-29 | 2024-01-30 | 217693 |
| MINT-ATORVASTATIN | 10MG | TABLET | Resolved | 2024-01-29 | 2024-01-30 | 217690 |
| MINT-BETAHISTINE | 24MG | TABLET | Actual shortage | 2024-06-10 | 2025-03-03 | 230044 |
| MINT-BETAHISTINE | 16MG | TABLET | Actual shortage | 2024-06-10 | 2025-03-03 | 230041 |
| MINT-BETAHISTINE | 8MG | TABLET | Actual shortage | 2024-06-10 | 2025-03-03 | 230038 |
| MINT-CANDESARTAN | 8MG | TABLET | Resolved | 2019-04-08 | 2019-06-15 | 80787 |
| MINT-CANDESARTAN | 8MG | TABLET | Resolved | 2019-07-24 | 2019-12-09 | 89913 |
| MINT-CANDESARTAN | 8MG | TABLET | Resolved | 2019-10-09 | 2019-11-29 | 95947 |
| MINT-CANDESARTAN | 16MG | TABLET | Resolved | 2019-01-03 | 2019-11-29 | 71041 |
| MINT-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2024-08-20 | 2024-10-08 | 235587 |
| MINT-CIPROFLOX | 500MG | TABLET | Resolved | 2018-07-31 | 2020-03-21 | 57055 |
| MINT-CIPROFLOX | 750MG | TABLET | Resolved | 2020-08-19 | 2022-06-06 | 122502 |
| MINT-CIPROFLOX | 250MG | TABLET | Resolved | 2020-04-25 | 2022-06-06 | 113184 |
| MINT-CITALOPRAM | 20MG | TABLET | Resolved | 2021-01-11 | 2021-06-22 | 131327 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-CITALOPRAM | 40MG | TABLET | Discontinued | 2023-05-02 | 2023-05-03 | 191442 |
| MINT-CITALOPRAM | 20MG | TABLET | Discontinued | 2023-05-02 | 2023-05-03 | 191439 |
| MINT-CLOPIDOGREL | Discontinued | 2019-02-04 | 2019-02-05 | 74442 | ||
| MINT-CLOPIDOGREL | Discontinued | 2019-02-04 | 2019-02-05 | 74435 | ||
| MINT-CLOPIDOGREL | 75MG | TABLET | Discontinued | 2018-08-16 | 2018-08-17 | 58286 |
| MINT-CLOPIDOGREL | 75MG | TABLET | Discontinued | 2018-08-16 | 2018-08-17 | 58283 |
| MINT-DORZOLAMIDE/TIMOLOL | 5MG 20MG | SOLUTION | Discontinued | 2019-06-04 | 2019-06-04 | 85525 |
| MINT-FENOFIBRATE E | 145MG | TABLET | Discontinued | 2020-04-25 | 2020-04-25 | 113175 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143952 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143956 |
| MINT-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143959 |
| MINT-LEVOFLOXACIN | 750MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170859 |
| MINT-LEVOFLOXACIN | 500MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170856 |
| MINT-LEVOFLOXACIN | 250MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170853 |
| MINT-METFORMIN | 500MG | TABLET | Discontinued | 2019-07-04 | 2019-07-05 | 88513 |
| MINT-METFORMIN | 850MG | TABLET | Discontinued | 2020-03-09 | 2020-03-10 | 108292 |
| MINT-RIVASTIGMINE | 4.5MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13565 |
| MINT-RIVASTIGMINE | 1.5MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13562 |
| MINT-RIVASTIGMINE | 6MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13559 |
| MINT-RIVASTIGMINE | 3MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13556 |